Host biology as a determinant of in vivo delivery and its translational potential
Clinical and Translational Medicine · 2026-08 · 16 (8)
DOI: 10.1002/ctm2.70791 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 24.08.2026. Verfasst von Qirui Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine, Centre for Advanced Interdisciplinary Science and …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, USTC Research Funds of the Double First-Class Initiative.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- State Key Laboratory of Immune Response and Immunotherapy, Division of Life Sciences and Medicine, Centre for Advanced Interdisciplinary Science and Biomedicine of IHM, University of Science and Technology of China, Hef…
ORCID-Profile: Yucai Wang
Förderung
- National Natural Science Foundation of China
- USTC Research Funds of the Double First-Class Initiative
Zitieren
APA
Liang, Q., Zhou, H., & Wang, Y. (2026). Host biology as a determinant of in vivo delivery and its translational potential. Clinical and Translational Medicine, 16(8). https://doi.org/10.1002/ctm2.70791
Vancouver
Liang Q, Zhou H, Wang Y. Host biology as a determinant of in vivo delivery and its translational potential. Clinical and Translational Medicine. 2026;16(8). doi:10.1002/ctm2.70791
BibTeX
@article{Liang2026,
author = {Liang, Qirui and Zhou, Han and Wang, Yucai},
title = {Host biology as a determinant of in vivo delivery and its translational potential},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {8},
doi = {10.1002/ctm2.70791}
}
EUVIMED